US 5012035A
· Sartori et al.
· 1991
[cited by applicant]
US 5173851A
· Off et al.
· 1992
[cited by applicant]
US 5595342A
· McNair et al.
· 1997
[cited by applicant]
US 5628530A
· Thornton
· 1997
[cited by applicant]
US 5726092A
· Mathews et al.
· 1998
[cited by applicant]
US 5757898A
· Nishikawa
· 1998
[cited by applicant]
US 5769228A
· Wroblewski
· 1998
[cited by applicant]
US 6012035A
· Freeman et al.
· 2000
[cited by applicant]
US 6111218A
· Akers et al.
· 2000
[cited by applicant]
US 6463462B1
· Smith et al.
· 2002
[cited by applicant]
US 6595342B1
· Maritzen et al.
· 2003
[cited by applicant]
US 6726092B2
· Goldberg et al.
· 2004
[cited by applicant]
US 6757898B1
· Ilsen et al.
· 2004
[cited by applicant]
US 6769228B1
· Mahar
· 2004
[cited by applicant]
US 7155397B2
· Alexander et al.
· 2006
[cited by applicant]
US 7192741B2
· Otte et al.
· 2007
[cited by applicant]
US 7337129B1
· Lowry et al.
· 2008
[cited by applicant]
US 7346768B2
· DiRienzo
· 2008
[cited by applicant]
US 7409632B1
· DiRienzo
· 2008
[cited by applicant]
US 7426476B2
· Munoz et al.
· 2008
[cited by applicant]
US 7734483B1
· Smith et al.
· 2010
[cited by applicant]
US 7783383B2
· Eliuk et al.
· 2010
[cited by applicant]
US 7840424B2
· Wiley et al.
· 2010
[cited by applicant]
US 7856364B1
· Wiley et al.
· 2010
[cited by applicant]
US 7912741B1
· Pinsonneault
· 2011
[cited by applicant]
US 7921021B1
· Newman
· 2011
[cited by applicant]
US 8036913B1
· Pinsonneault et al.
· 2011
[cited by applicant]
US 8036914B1
· Pinsonneault
· 2011
[cited by applicant]
US 8036918B1
· Pinsonneault
· 2011
[cited by applicant]
US 8050943B1
· Wiley et al.
· 2011
[cited by applicant]
US 8060379B1
· Pinsonneault et al.
· 2011
[cited by applicant]
US 8126743B1
· Wilk
· 2012
[cited by applicant]
US 8326773B1
· Bellamy
· 2012
[cited by applicant]
US 8346571B2
· Kalies, Jr.
· 2013
[cited by applicant]
US 8412537B1
· Fenton et al.
· 2013
[cited by applicant]
US 8442847B1
· Shrivastava
· 2013
[cited by applicant]
US 8489415B1
· Ringold
· 2013
[cited by applicant]
US 8521557B1
· Ringold et al.
· 2013
[cited by applicant]
US 8560340B1
· Ringold
· 2013
[cited by applicant]
US 8639523B1
· Pinsonneault
· 2014
[cited by applicant]
US 8645162B2
· Boerger et al.
· 2014
[cited by applicant]
US 8671018B2
· Thomas et al.
· 2014
[cited by applicant]
US 8712797B1
· Bezdek et al.
· 2014
[cited by applicant]
US 8738399B1
· Abou Nader et al.
· 2014
[cited by applicant]
US 8786650B1
· Eller et al.
· 2014
[cited by applicant]
US 8799018B1
· Rea et al.
· 2014
[cited by applicant]
US 8984059B2
· Johnson
· 2015
[cited by applicant]
US 9026507B2
· Shraim et al.
· 2015
[cited by applicant]
US 9100793B2
· Johnson
· 2015
[cited by applicant]
US 9171322B2
· Spievak et al.
· 2015
[cited by applicant]
US 9356947B2
· Shraim et al.
· 2016
[cited by applicant]
US 9760871B1
· Pourfallah et al.
· 2017
[cited by applicant]
US 9779129B1
· Lequeux
· 2017
[cited by applicant]
US 9786023B2
· Cohan et al.
· 2017
[cited by applicant]
US 20010034613A1
· Rubsamen
· 2001
[cited by applicant]
US 20010039589A1
· Aho et al.
· 2001
[cited by applicant]
US 20010056359A1
· Abreu
· 2001
[cited by applicant]
US 20020002495A1
· Ullman
· 2002
[cited by applicant]
US 20020004812A1
· Motoyama
· 2002
[cited by applicant]
US 20020032582A1
· Feeney et al.
· 2002
[cited by applicant]
US 20020035484A1
· McCormick
· 2002
[cited by applicant]
US 20020087583A1
· Morgan et al.
· 2002
[cited by applicant]
US 20020111832A1
· Judge
· 2002
[cited by applicant]
US 20020143579A1
· Docherty et al.
· 2002
[cited by applicant]
US 20020147614A1
· Doerr et al.
· 2002
[cited by applicant]
US 20020188552A1
· Kavounas et al.
· 2002
[cited by applicant]
US 20030009367A1
· Morrison
· 2003
[cited by applicant]
US 20030050799A1
· Jay et al.
· 2003
[cited by applicant]
US 20030069760A1
· Gelber
· 2003
[cited by applicant]
US 20030074234A1
· Stasny
· 2003
[cited by applicant]
US 20030130875A1
· Hawash et al.
· 2003
[cited by applicant]
US 20030149625A1
· Leonardi et al.
· 2003
[cited by applicant]
US 20030229540A1
· Algiene
· 2003
[cited by applicant]
US 20040006490A1
· Gingrich et al.
· 2004
[cited by applicant]
US 20040039599A1
· Fralic
· 2004
[cited by applicant]
US 20040073456A1
· Gottlieb et al.
· 2004
[cited by applicant]
US 20040078222A1
· Khan et al.
· 2004
[cited by applicant]
US 20040078234A1
· Tallal, Jr.
· 2004
[cited by applicant]
US 20040103062A1
· Wood et al.
· 2004
[cited by applicant]
US 20040199545A1
· Wagner et al.
· 2004
[cited by applicant]
US 20040249745A1
· Baaren
· 2004
[cited by applicant]
US 20050015280A1
· Gabel et al.
· 2005
[cited by applicant]
US 20050075932A1
· Mankoff
· 2005
[cited by applicant]
US 20050080692A1
· Padam et al.
· 2005
[cited by applicant]
US 20050102169A1
· Wilson
· 2005
[cited by applicant]
US 20050154627A1
· Zuzek et al.
· 2005
[cited by applicant]
US 20050187793A1
· Myles
· 2005
[cited by applicant]
US 20050197862A1
· Paterson et al.
· 2005
[cited by applicant]
US 20050240442A1
· Lapsker et al.
· 2005
[cited by applicant]
US 20050240473A1
· Ayers, Jr. et al.
· 2005
[cited by applicant]
US 20050261939A1
· Augspurger et al.
· 2005
[cited by applicant]
US 20060020514A1
· Yered
· 2006
[cited by applicant]
US 20060026041A1
· Ullman
· 2006
[cited by applicant]
US 20060036470A1
· Oaks
· 2006
[cited by applicant]
US 20060085231A1
· Brofman
· 2006
[cited by applicant]
US 20060149595A1
· Williams et al.
· 2006
[cited by applicant]
US 20060149784A1
· Tholl et al.
· 2006
[cited by applicant]
US 20060184391A1
· Barre et al.
· 2006
[cited by applicant]
US 20060212345A1
· Soza et al.
· 2006
[cited by applicant]
US 20060224414A1
· Astrup et al.
· 2006
[cited by applicant]
US 20060224417A1
· Werner
· 2006
[cited by applicant]
US 20060224443A1
· Soza et al.
· 2006
[cited by applicant]
US 20060235747A1
· Hammond et al.
· 2006
[cited by applicant]
US 20060259363A1
· Jhetam et al.
· 2006
[cited by applicant]
US 20070005402A1
· Kennedy et al.
· 2007
[cited by applicant]
US 20070033137A1
· Provost et al.
· 2007
[cited by applicant]
US 20070043589A1
· Warren et al.
· 2007
[cited by applicant]
US 20070043595A1
· Pederson
· 2007
[cited by examiner]
US 20070050209A1
· Yered
· 2007
[cited by applicant]
US 20070050210A1
· Wiley, II
· 2007
[cited by applicant]
US 20070067186A1
· Brenner et al.
· 2007
[cited by applicant]
US 20070094133A1
· Anandarao et al.
· 2007
[cited by applicant]
US 20070136100A1
· Daugherty et al.
· 2007
[cited by applicant]
US 20070162303A1
· Wiley et al.
· 2007
[cited by applicant]
US 20070185799A1
· Harrison et al.
· 2007
[cited by applicant]
US 20070191985A1
· Bain
· 2007
[cited by applicant]
US 20070202886A1
· Dhebri et al.
· 2007
[cited by applicant]
US 20070204043A1
· Espinosa et al.
· 2007
[cited by applicant]
US 20070219813A1
· Moore
· 2007
[cited by applicant]
US 20070233525A1
· Boyle
· 2007
[cited by applicant]
US 20070250341A1
· Howe et al.
· 2007
[cited by applicant]
US 20070260750A1
· Feied et al.
· 2007
[cited by applicant]
US 20070299915A1
· Shraim et al.
· 2007
[cited by applicant]
US 20080033750A1
· Swiss et al.
· 2008
[cited by applicant]
US 20080103836A1
· Park et al.
· 2008
[cited by applicant]
US 20080183492A1
· Warren et al.
· 2008
[cited by applicant]
US 20080215361A1
· Nunnari et al.
· 2008
[cited by applicant]
US 20090006141A1
· Karr
· 2009
[cited by applicant]
US 20090083064A1
· Mahinda
· 2009
[cited by applicant]
US 20090100099A1
· Buckwalter
· 2009
[cited by applicant]
US 20090106313A1
· Boldyga
· 2009
[cited by applicant]
US 20090112707A1
· Weiss et al.
· 2009
[cited by applicant]
US 20090204477A1
· Urso
· 2009
[cited by applicant]
US 20090287558A1
· Seth et al.
· 2009
[cited by applicant]
US 20090313112A1
· Champ et al.
· 2009
[cited by applicant]
US 20090327363A1
· Cullen et al.
· 2009
[cited by applicant]
US 20100057640A1
· Cannata
· 2010
[cited by applicant]
US 20100161353A1
· Mayaud
· 2010
[cited by applicant]
US 20100217622A1
· Brown et al.
· 2010
[cited by applicant]
US 20100287001A1
· Pearce et al.
· 2010
[cited by applicant]
US 20110015978A1
· Welch, Jr.
· 2011
[cited by applicant]
US 20110112871A1
· Simonowski et al.
· 2011
[cited by applicant]
US 20110161109A1
· Pinsonneault et al.
· 2011
[cited by applicant]
US 20110196697A1
· Akers
· 2011
[cited by applicant]
US 20120053958A1
· Marshall et al.
· 2012
[cited by applicant]
US 20120136809A1
· Cannata et al.
· 2012
[cited by applicant]
US 20120166268A1
· Griffiths
· 2012
[cited by applicant]
US 20120179481A1
· Patel et al.
· 2012
[cited by applicant]
US 20120185263A1
· Emert
· 2012
[cited by applicant]
US 20120185264A1
· Demogenes et al.
· 2012
[cited by applicant]
US 20120253829A1
· John et al.
· 2012
[cited by applicant]
US 20120253830A1
· John et al.
· 2012
[cited by applicant]
US 20120253831A1
· John et al.
· 2012
[cited by applicant]
US 20120253832A1
· John et al.
· 2012
[cited by applicant]
US 20120253833A1
· John et al.
· 2012
[cited by applicant]
US 20120253846A1
· John
· 2012
[cited by examiner]
US 20120303382A1
· Paul et al.
· 2012
[cited by applicant]
US 20130046610A1
· Abraham
· 2013
[cited by applicant]
US 20130144715A1
· Kranzley et al.
· 2013
[cited by applicant]
US 20130179180A1
· Patra
· 2013
[cited by applicant]
US 20130191147A1
· Harrell
· 2013
[cited by applicant]
US 20130246082A1
· Brylawski et al.
· 2013
[cited by applicant]
US 20140039911A1
· Iyer
· 2014
[cited by examiner]
US 20140088985A1
· Grant et al.
· 2014
[cited by applicant]
US 20140214435A1
· Previdi
· 2014
[cited by applicant]
US 20140249861A1
· Gamble et al.
· 2014
[cited by applicant]
US 20140278456A1
· Milosevich et al.
· 2014
[cited by applicant]
US 20140278531A1
· Gupta
· 2014
[cited by applicant]
US 20150032465A1
· Sundar et al.
· 2015
[cited by applicant]
US 20150088557A1
· Huynh et al.
· 2015
[cited by applicant]
US 20150142479A1
· Porter et al.
· 2015
[cited by applicant]
US 20150154565A1
· Kaehler et al.
· 2015
[cited by applicant]
US 20150154588A1
· Purves et al.
· 2015
[cited by applicant]
US 20150269695A1
· Pinsonneault et al.
· 2015
[cited by applicant]
US 20150278472A1
· King
· 2015
[cited by applicant]
US 20150332422A1
· Gilmartin
· 2015
[cited by applicant]
US 20160012465A1
· Sharp
· 2016
[cited by applicant]
US 20160103978A1
· Stong
· 2016
[cited by examiner]
US 20160267544A1
· Flood et al.
· 2016
[cited by applicant]
US 20160267545A1
· Glass et al.
· 2016
[cited by applicant]
US 20160307195A1
· Cantwell et al.
· 2016
[cited by applicant]
US 20160321406A1
· Timmerman et al.
· 2016
[cited by applicant]
US 20160321410A1
· Timmerman et al.
· 2016
[cited by applicant]
US 20160358142A1
· Hillen
· 2016
[cited by applicant]
US 20160358293A1
· Berger et al.
· 2016
[cited by applicant]
US 20170039331A1
· Bezdek et al.
· 2017
[cited by applicant]
US 20170220768A1
· Tanner, Jr. et al.
· 2017
[cited by applicant]
US 20170323295A1
· Kranzley et al.
· 2017
[cited by applicant]
US 20170324695A1
· Fischer et al.
· 2017
[cited by applicant]
US 20170329922A1
· Eberting et al.
· 2017
[cited by applicant]
US 20180012244A1
· Leonardi
· 2018
[cited by applicant]
US 20180075212A1
· Kubey
· 2018
[cited by applicant]
US 20180366810A1
· Nero et al.
· 2018
[cited by applicant]
US 20190371444A1
· Glass et al.
· 2019
[cited by applicant]
US 20200105392A1
· Karkazis et al.
· 2020
[cited by applicant]
US 20200143946A1
· Lewis
· 2020
[cited by applicant]
US 20200372988A1
· Bezdek et al.
· 2020
[cited by applicant]
US 20200395114A1
· Bachwani
· 2020
[cited by applicant]
US 20210319887A1
· Derrick, Jr. et al.
· 2021
[cited by applicant]
US 20210374872A1
· Stewart et al.
· 2021
[cited by applicant]
US 20210407642A1
· Xia et al.
· 2021
[cited by applicant]
AU 2003243327A
· 2003
[cited by applicant]
CA 2482370A1
· 2006
[cited by applicant]
CA 2792252A1
· 2013
[cited by applicant]
CA 2810686A1
· 2013
[cited by applicant]
CN 102362778
· 2012
[cited by applicant]
KR 100755440
· 2007
[cited by applicant]
KR 100793852
· 2008
[cited by applicant]
KR 101038074
· 2011
[cited by applicant]
KR 101101692
· 2011
[cited by applicant]
KR 20110138108
· 2011
[cited by applicant]
KR 20110138572
· 2011
[cited by applicant]
KR 101154858
· 2012
[cited by applicant]
WO WO1991006917A1
· 1991
[cited by applicant]
WO WO1995003569A2
· 1995
[cited by applicant]
WO WO1997025682A1
· 1997
[cited by applicant]
WO WO1998050871A1
· 1998
[cited by applicant]
WO WO2000039737A1
· 2000
[cited by applicant]
WO WO2003098401A2
· 2003
[cited by applicant]
WO WO2007025295A2
· 2007
[cited by applicant]
WO WO2007094772A1
· 2007
[cited by applicant]
WO WO2008092109A2
· 2008
[cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 17/162,461, dated Aug. 24, 2023, 2 pages, US.
[cited by applicant]
American Hospital Association, “Drug Price Proposals”, dated Apr. 2019, retrieved from the Internet at <URL: https://www.aha.org/system/files/media/file/2019/04/aha-drug-policy-recommendations_2.pdf>, 8 pages.
[cited by applicant]
California Health Care Foundation, “When the Price Is Not Right: State Options on Prescription Drug Pricing”, dated Jun. 2016, retrieved from the Internet at: <URL: https://www.chcf.org/wp-content/uploads/2017/12/PDF-Wh…
[cited by applicant]
Hsee, Christopher K., et al., “General Evaluability Theory”, Perspectives on Psychological Science, Jul. 2010, pp. 343-355, vol. 5, No. 4, Sage Publications, Inc. on behalf of the Association for Psychological Science r…
[cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 16/867,286, dated Dec. 6, 2022, 8 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 17/175,939, dated Dec. 22, 2022, 5 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 17/144,426, dated Dec. 8, 2022, 21 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Notice of Allowance received for U.S. Appl. No. 16/832,318, dated Dec. 8, 2022, 26 pages, US.
[cited by applicant]
Van Nuys, Ph.D., Karen, et al., “Prescription Drug Copayment Coupon Landscape”, Drug Pricing White Paper, USC Leonard D. Schaeffer Center for Health Policy and Economics, Feb. 7, 2018, retrieved from the Internet at <UR…
[cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 17/144,426, dated Mar. 21, 2024, 5 pages.
[cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 17/674,366, dated Mar. 22, 2024, 6 pages.
[cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 17/705,919, dated Feb. 28, 2024, 61 pages.
[cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 17/175,939, dated Mar. 1, 2024, 24 pages.
[cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 16/816,460, dated Aug. 1, 2024, 3 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 17/162,461, dated Aug. 19, 2024, 2 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 18/098,150, dated Aug. 27, 2024, 61 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Interview Summary received for U.S. Appl. No. 17/675,616, dated Aug. 15, 2024, 8 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 16/832,318, dated Jan. 28, 2022, 4 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 16/867,286, dated Feb. 22, 2022, 38 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Notice of Allowance received for U.S. Appl. No. 17/219,526, dated Feb. 3, 2022, 48 pages, U.S.
[cited by applicant]
Zhu, V. et al., “Data for drugs available through low-cost prescription drug programs are available through pharmacy benefit manager and claims data,” BMC Clinical Pharmacology, Jun. 22, 2012, vol. 12, No. 12., BioMed C…
[cited by applicant]
Coase, R. H., “The Nature of the Firm”, Economica, Nov. 1937, pp. 386-405, vol. 4, No. 16, Blackwell Publishing for London School of Economics and Political Science, retrieved from the Internet at http://www.jstor.org/s…
[cited by applicant]
Gemmill, Marin, “The price elasticity of demand for prescription drugs: An exploration of demand in different settings”, Doctor of Philosophy Thesis submitted to the London School of Economics and Political Science, Jan…
[cited by applicant]
United States Patent and Trademark Office, Advisory Action and Examiner-Initiated Interview Summary received for U.S. Appl. No. 17/705,919, dated Jun. 25, 2024, 33 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Examiner's Answer received for U.S. Appl. No. 16/867,286, dated Jun. 28, 2024, 9 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/144,426, dated Jul. 18, 2024, 19 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/158,118, dated Jul. 18, 2024, 22 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Notice of Allowance received for U.S. Appl. No. 17/846,373, dated Jul. 25, 2024, 16 pages, US.
[cited by applicant]
U.S. Appl. No. 16/816,460, “Adaptive System and Method for Adjudicating Claims to Reduce Member Responsibility”, Unpublished (Filing Date Mar. 12, 2020), (Michael Rea, Inventor), (RC Savings, LLC, Assignee).
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 16/816,460, dated Mar. 3, 2023, 14 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 17/162,461, dated May 19, 2023, 23 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 17/158,118, dated May 26, 2023, 5 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/674,366, dated Jun. 6, 2023, 75 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Miscellaneous Office Action, Restarting Period, received for U.S. Appl. No. 17/175,939, dated Jun. 14, 2023, 23 pages, U.S.
[cited by applicant]
Viswanthan, Meera, et al., “Interventions to Improve Adherence to Self-administered Medications for Chronic Diseases in the United States,” Annals of Internal Medicine, Dec. 4, 2012, retrieved from the Internet at <http…
[cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 16/816,460, dated Aug. 10, 2023, 14 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/144,426, dated Jul. 13, 2023, 17 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/158,118, dated Jul. 13, 2023, 18 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 16/867,286, dated Sep. 19, 2023, 16 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 16/816,460, dated Oct. 19, 2023, 3 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/162,461, dated Oct. 19, 2023, 25 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/705,919, dated Aug. 17, 2023, 68 pages, US.
[cited by applicant]
Google NPL (non-patent literature) Search on “pharmacy payment benefit copay NDC database”, retrieved from the Internet at <https://scholar.google.com/scholar?hl=en&as_sdt=3,47&g=pharmacy+payment+benefit+copay+NDC+datab…
[cited by applicant]
Google NPL (non-patent literature) Search on “pharmacy payment benefit copay NDC database”, retrieved from the Internet at <https://www.google.com/search?g=pharmacy+payment+benefit+copay+ndc+database&source=int&tbs=cdr%…
[cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 16/792,413, dated Mar. 10, 2022, 4 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Notice of Allowance and Fee(s) Due received for U.S. Appl. No. 17/219,526, dated Mar. 22, 2022, 11 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Notice of Allowance and Fee(s) Due received for U.S. Appl. No. 16/551,962, dated Mar. 16, 2022, 10 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Notice of Allowance and Fee(s) Due received for U.S. Appl. No. 17/092,705, dated Mar. 24, 2022, 9 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Notice of Allowance and Fee(s) Due received for U.S. Appl. No. 16/551,962, dated Mar. 1, 2022, 14 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/674,366, dated Jun. 5, 2024, 54 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 17/162,461, dated Jun. 4, 2024, 38 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 16/867,286, dated Mar. 31, 2023, 16 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/175,939, dated Apr. 26, 2023, 24 pages, US.
[cited by applicant]
United States Patent and Trademark Office, Notice of Allowance received for U.S. Appl. No. 15/085,166, dated Jun. 15, 2022, 18 pages, U.S.
[cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 17/012,565, dated Jul. 25, 2022, 43 pages, U.S.
[cited by applicant]
Pharmacy Reject Codes NCPDP, 5 pages.
[cited by applicant]
St. Vincent's first to use Birmingham startup's information system. The Birmingham News [Online] Apr. 11, 2005. URL: http://www.awarix.com.
[cited by applicant]
St. Vincent's is Digital Flagship D. Lockridge; Birmingham Medical News [Online] Sep. 2005.
[cited by applicant]
Two automatic identification technology, neither new in the sense if being recent developments . . . Patient Safety & Quality Healthcare [Online] Aug. 2005_ URL: http://www_awarix.com.
[cited by applicant]
Advisory Action for U.S. Appl. No. 14/193,294 mailed Nov. 9, 2017, 3 pages.
[cited by applicant]
Advisory Action for U.S. Appl. No. 15/085,166 dated Apr. 11, 2019, 4 pages.
[cited by applicant]
Advisory Action for U.S. Appl. No. 15/085,166 dated Apr. 29, 2020, 3 pages.
[cited by applicant]
Advisory Action for U.S. Appl. No. 15/137,371 mailed Feb. 25, 2019, 5 pages.
[cited by applicant]
Advisory Action for U.S. Appl. No. 15/427,746 mailed Jul. 2, 2019, 2 pages.
[cited by applicant]
Advisory Action received for U.S. Appl. No. 15/085,166, dated Jan. 29, 2021, 3 pages, US.
[cited by applicant]
Almaro, Moshe; “Recovery and Reuse of Unused Prescription Drugs” MIT What Matters: Aug. 2005.
[cited by applicant]
American Society of Health-System Pharmacists (ASHP), “Is Prescribing the Next Step in the Evolution of Pharmacy?” May 15, 2012.
[cited by applicant]
Anonymous, ACS to Demonstrate Electronic Health Record Solution Suite at MMIS 2007 Conference; EHR Tools Consolidate Data, Provide Useful Information at the Point of Care for Medicaid Providers, Payers, and Patients, PR…
[cited by applicant]
Anonymous, Medic; On-line Goes In-House, Chain Store Age Executive, Jan. 1987, vol. 63, Issue 1, USA; Abstract only.
[cited by applicant]
Anonymous, Pharmacy Industry Leaders Launch Firm to Supply Real-Time Data, PR Newswire, Jul. 30, 2001, p. 1, New York, NY, USA.
[cited by applicant]